| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Black Diamond Therapeutics, Inc. | Officer Title: President and Chief Executive Officer, Director | Common Stock | 671,423 | $1,832,985 | $2.73 | 27 Jun 2023 | Direct |
| Black Diamond Therapeutics, Inc. | Officer Title: President and Chief Executive Officer, Director | Common Stock | 16,579 | $45,261 | $2.73 | 27 Jun 2023 | Indirect |
| GYRE THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 26,000 | 04 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GYRE | GYRE THERAPEUTICS, INC. | 04 Jun 2025 | 1 | $0 | 4 | Director | 06 Jun 2025, 16:22 |
| GYRE | GYRE THERAPEUTICS, INC. | 14 Aug 2024 | 1 | $0 | 4 | Director | 16 Aug 2024, 21:07 |
| GYRE | GYRE THERAPEUTICS, INC. | 06 Aug 2024 | 1 | $0 | 4 | Director | 08 Aug 2024, 16:31 |
| GYRE | GYRE THERAPEUTICS, INC. | 06 Aug 2024 | 0 | $0 | 3 | Director | 08 Aug 2024, 16:23 |
| BDTX | Black Diamond Therapeutics, Inc. | 27 Jun 2023 | 1 | -$167,500 | 4 | Officer Title: President and Chief Executive Officer, Director | 28 Jun 2023, 16:02 |
| BDTX | Black Diamond Therapeutics, Inc. | 13 Feb 2023 | 1 | $0 | 4 | Officer Title: President and Chief Executive Officer, Director | 15 Feb 2023, 15:10 |
| BDTX | Black Diamond Therapeutics, Inc. | 15 Feb 2022 | 1 | $0 | 4 | Officer Title: President and Chief Executive Officer, Director | 17 Feb 2022, 15:19 |